BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7994252)

  • 1. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation.
    Ferster A; Bujan W; Mouraux T; Devalck C; Heimann P; Sariban E
    Bone Marrow Transplant; 1994 Aug; 14(2):331-2. PubMed ID: 7994252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.
    Yazaki M; Andoh M; Ito T; Ohno T; Wada Y
    Bone Marrow Transplant; 1997 Feb; 19(4):393-4. PubMed ID: 9051252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients.
    Russell LA; Jacobsen N; Heilmann C; Simonsen AC; Christensen LD; Vindelov LL
    Bone Marrow Transplant; 1996 Aug; 18(2):411-4. PubMed ID: 8864454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party.
    Dini G; Cornish JM; Gadner H; Souillet G; Vossen JM; Paolucci P; Manfredini L; Miano M; Niethammer D
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():4-7. PubMed ID: 8932789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.
    van der Griend R; Verdonck LF; Petersen EJ; Veenhuizen P; Bloem AC; Lokhorst HM
    Bone Marrow Transplant; 1999 Jan; 23(2):195-7. PubMed ID: 10197809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma.
    Moritake H; Ikuno Y; Tasaka H; Koga H; Miyazaki S; Okamura J
    Bone Marrow Transplant; 1998 Apr; 21(7):725-6. PubMed ID: 9578314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
    Chang CS; Lin SF; Liu TC; Huang SM; Chen TP
    J Formos Med Assoc; 1998 Jan; 97(1):55-8. PubMed ID: 9481066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
    Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
    Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.
    Grigg A; Szer J
    Bone Marrow Transplant; 1996 Sep; 18(3):647-8. PubMed ID: 8879633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor leukocyte infusions in acute lymphocytic leukemia.
    Collins RH; Goldstein S; Giralt S; Levine J; Porter D; Drobyski W; Barrett J; Johnson M; Kirk A; Horowitz M; Parker P
    Bone Marrow Transplant; 2000 Sep; 26(5):511-6. PubMed ID: 11019840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
    Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute polymyositis after donor lymphocyte infusion.
    Lin PC; Hsiao LT; Chen PM
    Eur J Haematol; 2005 Feb; 74(2):166-8. PubMed ID: 15654909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.